Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays a new revision tag, updating from v3.6.6 to v3.7.0, indicating an update to the page rendering/version. This change does not modify study content or user-facing data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a new revision tag v3.6.6 replacing v3.6.5, indicating a small update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new Revision: v3.6.5 tag appears in the page footer, replacing Revision: v3.6.4. This reflects a version update of the page/interface rather than a modification to the study details or user-visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small behind-the-scenes update to the page template or rendering.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision number updated from v3.6.2 to v3.6.3. This reflects a minor update to the page's metadata and documentation rather than any changes to study data or user-facing content.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter revision label changed from v3.6.0 to v3.6.2, representing a small page update without altering study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.